Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Colorectal Neoplasms

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Colorectal Neoplasms in 2 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaefer, KL1
Takahashi, H1
Morales, VM1
Harris, G1
Barton, S1
Osawa, E1
Nakajima, A1
Saubermann, LJ1
Fehlberg, S1
Trautwein, S1
Göke, A1
Göke, R1

Other Studies

2 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Colorectal Neoplasms

ArticleYear
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
    International journal of cancer, 2007, Feb-01, Volume: 120, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Anilides; Animals; Apoptosis; Benzamides; Benzhydryl Compounds; Cac

2007
Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners.
    The Biochemical journal, 2002, Mar-15, Volume: 362, Issue:Pt 3

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Benzhydryl Compounds; Carcinogens; Carcinoma; Caspases; Ce

2002